C Jo White
Overview
Explore the profile of C Jo White including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
332
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lee J, Menacherry S, Diehl M, Giffear M, White C, Juba R, et al.
Clin Pharmacol Drug Dev
. 2016 May;
5(2):91-101.
PMID: 27138022
VGX-1027, a novel oral immune modulator, is under development for the treatment of rheumatoid arthritis. The safety, tolerability, and pharmacokinetics of single (1-800 mg) and multiple (40-400 mg) oral doses...
2.
Tussey L, Strout C, Davis M, Johnson C, Lucksinger G, Umlauf S, et al.
Open Forum Infect Dis
. 2016 Mar;
3(1):ofw015.
PMID: 26925433
Background. We evaluated the safety and immunogenicity of VAX2012Q, a quadrivalent influenza vaccine comprising 4 hemagglutinin subunits fused to flagellin. Methods. In this dose-ranging, open-label study, healthy adults (18-40 years)...
3.
McKittrick N, Frank I, Jacobson J, White C, Kim D, Kappes R, et al.
Ann Intern Med
. 2013 Jan;
158(1):19-26.
PMID: 23277897
Background: HIV-infected persons have less robust antibody responses to influenza vaccines. Objective: To compare the immunogenicity of high-dose influenza vaccine with that of standard dosing in HIV-positive participants. Design: Randomized,...
4.
Schmidt C, White C, Ibrahim A, Filler S, Fu Y, Yeaman M, et al.
Vaccine
. 2012 Oct;
30(52):7594-600.
PMID: 23099329
The investigational vaccine, NDV-3, contains the N-terminal portion of the Candida albicans agglutinin-like sequence 3 protein (Als3p) formulated with an aluminum hydroxide adjuvant in phosphate-buffered saline. Preclinical studies demonstrated that...
5.
Bagarazzi M, Yan J, Morrow M, Shen X, Parker R, Lee J, et al.
Sci Transl Med
. 2012 Oct;
4(155):155ra138.
PMID: 23052295
Despite the development of highly effective prophylactic vaccines against human papillomavirus (HPV) serotypes 16 and 18, prevention of cervical dysplasia and cancer in women infected with high-risk HPV serotypes remains...
6.
Para M, Schouten J, Rosenkranz S, Yu S, Weiner D, Tebas P, et al.
J Acquir Immune Defic Syndr
. 2010 Feb;
53(4):491-5.
PMID: 20130470
Background: Mifepristone is a glucocorticoid receptor inhibitor shown in vitro to have anti-HIV activity and anti-simian immunodeficiency virus activity in a macaque model. A phase I/II trial was performed to...